HMGA2 associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective
HMGA2-assoziierter ceRNA-HOTAIR-Weg bei Brustkrebspatientinnen aus klinisch-pathologischer Perspektive
Turkish Journal of Medical Sciences · 20.06.2025 · 55 (3) · 782-791
DOI: 10.55730/1300-0144.6027 ↗Auf einen Blick
Bei 40 Brustkrebspatientinnen und 10 gesunden Kontrollen war HOTAIR höher und HMGA2 bei Rezidiv höher. Weitere Unterschiede zeigten sich nach ER-Status und Menopausenstatus.
Fragestellung
Wird der HMGA2-assoziierte ceRNA-HOTAIR-Weg bei Brustkrebspatientinnen mit klinisch-pathologischen Gruppenunterschieden assoziiert?
Methode
40 Brustkrebspatientinnen und 10 gesunde Kontrollen; Zell-freie RNA aus peripherem Blut; Real-Time PCR; Einteilung in klinisch-pathologische Gruppen.
Ergebnisse
HOTAIR war in der Studiengruppe höher als in den Kontrollen, besonders in der ER-negativen Gruppe (p=0,006). HMGA2 war bei Rezidiv höher (p=0,048). MiR-20a-5p war prämenopausal höher (p=0,002); HMGA2 dort niedriger (p=0,002).
Schlussfolgerung der Autor:innen
Die Autor:innen sehen den HMGA2-assoziierten HOTAIR-Achsenweg als möglichen prognostischen Biomarker und therapeutisches Ziel, besonders bei ER-negativem, postmenopausalem und rezidiviertem Brustkrebs.
Kernaussagen
- HOTAIR höher in der Studiengruppe, besonders bei ER-negativem Brustkrebs
- HMGA2 höher bei Rezidiv
- Assoziationen mit Menopausenstatus und Alter wurden beschrieben
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 20.06.2025. Verfasst von Pelin Ercoşkun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkiye. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Long Noncoding, HMGA2 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/aim: Several epigenetic alterations are involved in the development of breast cancer. The long noncoding RNA HOTAIR and related RNAs play a role in initiation of breast cancer and are promising targets for diagnostic biomarker and therapeutic studies. In this study, we aimed to investigate HMGA2 associated ceRNA HOTAIR pathway in breast cancer patients. Materials and methods: Forty breast cancer patients and ten healthy controls were included in this study, and then patients were divided into clinicopathologic groups. After total cell-free RNA isolation, expression levels of target RNAs were analysed by Real-Time PCR. The amount of gene expression was determined according to delta-delta Ct method and change in the expression was determined using the 2-ΔΔCt method.
Results
HOTAIR expression was significantly higher in the study group (especially in the ER negative group) than in the control group (p value = 0.006). When patients with relapse were compared with those without relapse, HMGA2 expression was significantly higher (p value = 0.048). There was a significant increase in miR-20a-5p expression (p value = 0.002) in the premenopausal group compared to the postmenopausal group, while there was a significant decrease in HMGA2 expression (p value = 0.002). A positive correlation between patient age and HMGA2 and a negative correlation between patient age and miR-20a-5p were found (respectively p value: 0.037 and p value: 0.006). Also, we found a negative correlation between HMGA2 and miR-20a-5p (p value: 0.027, correlation coefficient: –0.350).
Conclusion
To our knowledge, this study is the first to examine the association of the HMGA2 associated HOTAIR axis with breast cancer in cell-free RNA from peripheral blood of patients. Our findings emphasize the potential of the HMGA2 associated HOTAIR axis as a prognostic biomarker and therapeutic target, especially in ER negative, postmenopausal onset, and relapsed breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
- Department of General Surgery, Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
ORCID-Profile: Pelin Ercoşkun, Deniz Ağirbaşli, Mehmet Velidedeoğlu, Mehmet Seven, Aysel Kalayci
Zitieren
APA
Ercoşkun, P., Ağirbaşli, D., Velidedeoğlu, M., Seven, M., & Kalayci, A. (2025). HMGA2 associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective. Turkish Journal of Medical Sciences, 55(3), 782-791. https://doi.org/10.55730/1300-0144.6027
Vancouver
Ercoşkun P, Ağirbaşli D, Velidedeoğlu M, Seven M, Kalayci A. HMGA2 associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective. Turkish Journal of Medical Sciences. 2025;55(3):782-791. doi:10.55730/1300-0144.6027
BibTeX
@article{Ercokun2025,
author = {Ercoşkun, Pelin and Ağirbaşli, Deniz and Velidedeoğlu, Mehmet and Seven, Mehmet and Kalayci, Aysel},
title = {HMGA2 associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {3},
pages = {782--791},
doi = {10.55730/1300-0144.6027}
}
EUVIMED